Skip to main content
Pideka Group Inc. logo

Pideka Group Inc. — Investor Relations & Filings

Ticker · PDKA ISIN · CA72004D1069 CSE Manufacturing
Open in API
Filings indexed 81 across all filing types
Latest filing 2021-04-29 Management Reports
Country CA Canada
Listing CSE PDKA

About Pideka Group Inc.

https://www.grupopideka.com/

Pideka Group Inc. is a multi-national operator specializing in the cultivation, production, and distribution of pharmaceutical-grade cannabis and its derivatives. The company utilizes medical-grade indoor cultivation facilities and laboratories to produce raw cannabis flower and specialized derivatives intended for scientific and pharmaceutical applications. Pideka's product offerings include pharmaceutical grade cannabinoids, decarboxylated flower, finished CBD products, and finished ingredient cannabis oil. The company focuses on providing high-quality medicinal cannabis products designed to meet or exceed international standards, serving markets through integrated operations that include cultivation, production, and distribution.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Management Reports Classification · 100% confidence The document is titled 'Management’s Discussion & Analysis' (MD&A) for the three month period ended February 28, 2021. It contains detailed financial discussion, results of operations, liquidity and capital resources, quarterly results, and outlook. It references the company's financial statements and discusses business transactions and financial conditions in detail. The document is approximately 15,000 characters, indicating it is a full report rather than a brief announcement. The content matches the typical characteristics of a Management Reports document, which provides management's detailed explanation of financial results, business trends, and outlook for a specific interim period. Therefore, the appropriate classification is 'Management Reports' (MDA).
2021-04-29 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CEO of Ikänik Farms Inc. regarding the interim financial report and interim MD&A for the period ended February 28, 2021. It is a Form 52-109FV2, which is a certification of interim filings for a venture issuer. The content primarily consists of attestation statements about the accuracy and fair presentation of the interim filings, without containing actual financial data or substantive financial analysis. According to the CERTIFICATION RULE, documents that are primarily officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3024 characters), and it is clearly a certification form rather than the interim report or MD&A. Therefore, the correct classification is Regulatory Filings (RNS).
2021-04-29 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Ikänik Farms Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended February 28, 2021. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3032 characters), consistent with a certification letter rather than a full report.
2021-04-29 English
Interim financial statements/report – English.pdf
Earnings Release Classification · 90% confidence The document is a press release reporting the company's audited consolidated financial statements and management discussion & analysis for the year ended December 31, 2020. It mentions the availability of these documents on SEDAR but does not contain the full financial statements or detailed financial data itself. The text focuses on summarizing annual results, project updates, and forward-looking statements rather than presenting the full annual report. The document length is 7,082 characters, which is relatively short for a full annual report. It is an announcement of the annual results and references the full report elsewhere, fitting the pattern of an Earnings Release (ER) rather than the full Annual Report (10-K).
2021-04-29 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Ikänik Farms' subsidiary has registered and commercialized six CBD cosmetic products eligible for sale in several Latin American countries. It includes forward-looking statements and company background information. There is no indication of financial data, regulatory filings, management changes, voting results, or any formal report submission. The content is a corporate announcement about product registration and market expansion, which does not fit into any specific financial or regulatory filing categories such as Annual Report, Earnings Release, or Regulatory Filings. Given the nature of the announcement, it best fits under Regulatory Filings (RNS) as a general corporate announcement that does not fit other categories.
2021-04-22 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Ikänik Farms has received approval to commence trading on the German Börse-Frankfurt Exchange. It contains no financial statements, no detailed financial data, no management discussion of financial results, no voting results, no legal proceedings, no audit information, and no mention of any report filings. The content is focused on a capital market event—specifically, the start of trading on a new exchange. This fits the category of a Capital/Financing Update (CAP), as it relates to the company's capital market activities and financing accessibility. The document length is 4083 characters, which is short but contains substantive information about the trading commencement, not just an announcement of a report publication. Therefore, the best classification is CAP with high confidence.
2021-04-22 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.